Found review

What it is

A long-running weight-care service built around insurance rather than around compounding. Where the rest of this board sells one or two compounded molecules for cash, Found runs a formulary: branded GLP-1s filled through normal pharmacy channels, compounded semaglutide and tirzepatide, older weight medications including metformin, Contrave, topiramate and zonisamide, a microdosing program, and a branded product it lists as Foundayo and labels orforglipron. It also sells through employers and health plans, which is why the insurance machinery exists at all. Found states plainly that it is not affiliated with or endorsed by Novo Nordisk, Eli Lilly or Currax, whose brand names appear throughout its catalog.

How it works

The path starts with a free insurance check rather than a payment, which is a meaningfully different opening move from a checkout with a countdown clock. From there it is eligibility, a Found clinician who personalizes a prescription, and ongoing adjustment as you respond. The program is stated to include access to board-certified Found clinicians, a personalized care plan, healthy-habits guidance, and an AI concierge the service calls Aimee — a chatbot layer that is a convenience rather than clinical care, and worth reading as such. Found also publishes free tools outside the funnel: BMI, BMR, calorie, protein and waist-to-hip calculators, a GLP-1 eligibility checker, a Medicare-specific page and a resource center. The trade-off against a cash compounding shop is speed: an insurance route involves coverage checks, possible copays and prior authorizations that a $99 compounded vial does not.

Pricing transparency

Found publishes more numbers than almost anyone here, and every one of them carries a qualifier. The program headline is $99 a month with insurance or $169 with cash pay — both based on twelve-month plans paid up front. Its own footnote gives the month-to-month equivalents: $199 with insurance and $289 cash, with visits on insurance plans potentially requiring copays. Read that as the real spread. Brand-name medication is priced separately and openly: Ozempic at about $1,100 a month, Mounjaro at about $1,100, Wegovy and Zepbound from $650 and up, with Saxenda and Victoza listed as varying. Found also states in a homepage footnote that its advertised medication cost does not include subscription fees and clinical care, which vary with coverage — so the program fee and the medication are two separate lines, and only your own coverage check will produce a single number. A promotional $100 off is advertised, with terms distinguishing the annual-prepay saving from the checkout discount and excluding its Med Kit plans.

Branded vs compounded

The widest formulary on this board by a distance. Branded GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro, Rybelsus, Saxenda, Victoza and Trulicity — sit alongside compounded semaglutide and tirzepatide injections, older oral weight medications including metformin, Contrave, topiramate and zonisamide, a microdosing program, and Foundayo, which the page labels orforglipron. That range is the point: a reader whose insurance covers Wegovy, a reader who wants a cheap compounded vial, and a reader for whom a GLP-1 is the wrong drug entirely can all be served from one intake. Found cites the actual trial figures for the branded products it sells — an average 15% loss with Wegovy at 2.4 mg over 68 weeks and 20% with Zepbound at 15 mg over 72 weeks, against 2.4% and 3.1% on lifestyle changes alone — and notes that GLP-1s carry black-box warnings. Compounded preparations are not FDA-approved and are not therapeutically equivalent to the branded drugs, whichever route you end up on.

Pros and watch-outs

The evidence behind what Found prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Oral semaglutide (Rybelsus): what the PIONEER trials actually showed

  A GLP-1 peptide in a pill is hard to pull off. PIONEER 1, 4, and 6 plus OASIS 1 — read straight from the primary literature.

How Found compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Gala Health

  A guided, program-style GLP-1 weight-care experience

  See Gala Health →
• Trimi Health

  Low-cost compounded GLP-1 with thorough dosing guidance

  See Trimi Health →
• HEHealthRX

  Low-cost compounded GLP-1 with overnight shipping and physician review

  See HealthRX →

More GLP-1 telehealth reviews: Mochi Health · LifeMD · Form Health · PlushCare · Nolu · Glam Health